Literature DB >> 30250348

Complete Myocardial Function Recovery with ECMO in a Woman Presenting with Cardiogenic Shock during Peripartum Period.

Mukund Das1, Anil Rathi1, Ashwad Afzal1, Kumudha Ramasubbu1.   

Abstract

Peripartum cardiomyopathy is a potentially life-threatening cause of heart failure (HF) that affects women toward the end of pregnancy or in months after delivery. Treatment is similar to the treatment for HF with reduced ejection fraction (EF). Most women make full myocardial function recovery within 6 months on conventional HF therapy. In rare instances, catastrophic presentations may occur with hemodynamic instability requiring the use of mechanical support. Because of the small patient population, limited information is available regarding the recovery of myocardial function in women who received mechanical support. We present a case of a woman in her peripartum period who presented with cardiogenic shock and made complete myocardial function recovery after 4 days of extracorporeal membrane oxygenation (ECMO). Our patient's EF at the time of catastrophe was 5-10%, which improved to 60% on day 4 on ECMO.

Entities:  

Keywords:  cardiomyopathy; extracorporeal membrane oxygenation (ECMO); heart failure; mechanical circulatory support; postpartum

Mesh:

Year:  2018        PMID: 30250348      PMCID: PMC6146275     

Source DB:  PubMed          Journal:  J Extra Corpor Technol        ISSN: 0022-1058


  8 in total

Review 1.  Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy.

Authors:  Karen Sliwa; Denise Hilfiker-Kleiner; Mark C Petrie; Alexandre Mebazaa; Burkert Pieske; Eckhart Buchmann; Vera Regitz-Zagrosek; Maria Schaufelberger; Luigi Tavazzi; Dirk J van Veldhuisen; Hugh Watkins; Ajay J Shah; Petar M Seferovic; Uri Elkayam; Sabine Pankuweit; Zoltan Papp; Frederic Mouquet; John J V McMurray
Journal:  Eur J Heart Fail       Date:  2010-08       Impact factor: 15.534

Review 2.  The role of extracorporeal membrane oxygenation (ECMO) therapy in acute heart failure.

Authors:  Hiroshi Tsuneyoshi; Vivek Rao
Journal:  Int Anesthesiol Clin       Date:  2012

3.  Peripartum cardiomyopathy.

Authors:  J G Demakis; S H Rahimtoola
Journal:  Circulation       Date:  1971-11       Impact factor: 29.690

4.  Myocardial recovery in peripartum cardiomyopathy: prospective comparison with recent onset cardiomyopathy in men and nonperipartum women.

Authors:  Leslie T Cooper; Paul J Mather; Jeffrey D Alexis; Daniel F Pauly; Guillermo Torre-Amione; Ilan S Wittstein; G William Dec; Mark Zucker; Jagat Narula; Kevin Kip; Dennis M McNamara
Journal:  J Card Fail       Date:  2011-11-09       Impact factor: 5.712

5.  Frequency of peripartum cardiomyopathy.

Authors:  Lisa M Mielniczuk; Kathryn Williams; Darryl R Davis; Anthony S L Tang; Robert Lemery; Martin S Green; Michael H Gollob; Haissam Haddad; David H Birnie
Journal:  Am J Cardiol       Date:  2006-04-21       Impact factor: 2.778

6.  Improved outcomes in peripartum cardiomyopathy with contemporary.

Authors:  Ankie M Amos; Wissam A Jaber; Stuart D Russell
Journal:  Am Heart J       Date:  2006-09       Impact factor: 4.749

Review 7.  Peripartum Cardiomyopathy.

Authors:  Zolt Arany; Uri Elkayam
Journal:  Circulation       Date:  2016-04-05       Impact factor: 29.690

8.  Temporal trends in incidence and outcomes of peripartum cardiomyopathy in the United States: a nationwide population-based study.

Authors:  Dhaval Kolte; Sahil Khera; Wilbert S Aronow; Chandrasekar Palaniswamy; Marjan Mujib; Chul Ahn; Diwakar Jain; Alan Gass; Ali Ahmed; Julio A Panza; Gregg C Fonarow
Journal:  J Am Heart Assoc       Date:  2014-06-04       Impact factor: 5.501

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.